Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 5, 2001, Pages 1097-1100

  Gencay, M ^a   Rudiger J J ^a   Tamm, M ^a   Soler M ^a   Perruchoud, A P ^a   Roth, M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; FREQUENCY ANALYSIS; HUMAN; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0035029505     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.5.2003162     Document Type: Article

References (35)

1. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma
2. The seroepidemiology of chlamydiae in Finland over the period 1981-1987
3. Why has the utilisation of antiasthmatics increased in Finland?
4. TWAR: A newly discovered chlamydia organism that causes acute respiratory tract infections
5. Prevalence of asthma and hayfever in England and Wales
6. Epidemiology of asthma in Denmark
7. Chlamydial pneumonia and asthma: A potentially important relationship
8. Association of Chlamydia pneumoniae antibodies with recently symptomatic asthma
9. Serology of Chlamydia in relation to asthma and bronchial hyperresponsiveness
10. Acute exacerbations of asthma in adults: Role of Chlamydia pneumoniae infection
11. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma
12. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma
13. Interaction of chlamydia and host cells in vitro
14. Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey
15. Chlamydia pneumoniae associated with central nervous system infections
16. New pathogens for respiratory infections
17. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children
18. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
19. Chlamydia pneumoniae and chronic lung diseases
20. Chlamydia pneumoniae and exacerbations of asthma in adults
21. Respiratory viruses and exacerbations of asthma in adults
22. Asthma, atopy and Chlamydia pneumoniae antibodies in adults
23. Chlamydia pneumoniae and possible relationship to asthma: Serum immunoglobulins and histamine release in patients and controls
24. Chlamydia pneumoniae and asthma
25. Chlamydia pneumoniae: Serology, lung function decline, and treatment for respiratory diseases
26. Prevalence of Chlamydia pneumoniae in Japan. I.
27. Prevalence of Chlamydia pneumoniae antibodies in Hungary
28. Population prevalence of Chlamydia pneumoniae strain TWAR
29. Treatment of Chlamydia pneumoniae infection in adult asthma: A before-after trial
30. The association of Chlamydia pneumoniae infection and reactive airway disease in children
31. Two nucleotide transport proteins in Chlamydia trachomatis, one for net nucleoside triphosphate uptake and the other for transport of energy
32. Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia: NMR studies of living cells
33. Chlamydia and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
34. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators
35. β lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells